Loading…
Three sessions of radial extracorporeal shockwave therapy gives no additional benefit over “minimal-dose” radial extracorporeal shockwave therapy for patients with chronic greater trochanteric pain syndrome: a double-blinded, randomized, controlled trial
Objective: To investigate the outcomes following three weekly sessions of radial extra-corporeal shockwave therapy (rESWT) in patients with chronic greater trochanteric pain syndrome (GTPS) presenting to an NHS Sports Medicine Clinic in the UK.Design: Double-blinded randomised controlled trialSettin...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Default Article |
| Published: |
2021
|
| Subjects: | |
| Online Access: | https://hdl.handle.net/2134/12630968.v1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1818166970246234112 |
|---|---|
| author | Patrick Wheeler Chloe Dudson Rachel Calver Duncan Goodall Kim Gregory Harjinder Singh Kevin Boyd |
| author_facet | Patrick Wheeler Chloe Dudson Rachel Calver Duncan Goodall Kim Gregory Harjinder Singh Kevin Boyd |
| author_sort | Patrick Wheeler (1248546) |
| collection | Figshare |
| description | Objective: To investigate the outcomes following three weekly sessions of radial extra-corporeal shockwave therapy (rESWT) in patients with chronic greater trochanteric pain syndrome (GTPS) presenting to an NHS Sports Medicine Clinic in the UK.Design: Double-blinded randomised controlled trialSetting: A single NHS Sports Medicine Clinic, in the United Kingdom.Patients: 120 patients in an NHS Sports Medicine clinic presenting with symptoms of GTPS that had failed to improve with a minimum of three months of rehabilitation were enrolled in the study, randomised equally to the intervention and treatment groups. Mean age 60.6±11.5years, 82% female, mean duration of symptoms 45.4±33.4 months (range: 6months-30years.)Interventions: Participants were randomised to receive either three sessions of ESWT at either the “recommended”/“maximally comfortably tolerated” dose or at “minimal-dose”. All patients received a structured home exercise programme involving flexibility, strength and balance exercises.Main outcome measures: Follow-up was 6-weeks, 3-months, and 6-months. Outcome measures included local hip pain, validated hip PROMs (OHS, NAHS, VISA-G) and wider measures of function including sleep (PSQI) and mood (HADS).Results: Results were available for 98% of patients at the 6-month period. There were statistically significant within-group improvements in pain, local function, and sleep seen in both groups. However, fewer benefits were seen in other outcome measures including activity or mood.Conclusion: There were no time*group interaction effects seen between the groups at any time-point, indicating that 3 sessions the “recommended-dose” rESWT had no measurable benefit compared to “minimal-dose” rESWT in this group of patients with GTPS. The underlying reason remains unclear, it may be that rESWT is ineffective in the treatment of patients with chronic GTPS, that “minimal-dose” rESWT is sufficient for a therapeutic effect, or that a greater number of treatment sessions are required for maximal benefit. These issues need to be considered in further research. |
| format | Default Article |
| id | rr-article-12630968 |
| institution | Loughborough University |
| publishDate | 2021 |
| record_format | Figshare |
| spelling | rr-article-126309682021-01-20T00:00:00Z Three sessions of radial extracorporeal shockwave therapy gives no additional benefit over “minimal-dose” radial extracorporeal shockwave therapy for patients with chronic greater trochanteric pain syndrome: a double-blinded, randomized, controlled trial Patrick Wheeler (1248546) Chloe Dudson (9104306) Rachel Calver (9104309) Duncan Goodall (8984540) Kim Gregory (9104312) Harjinder Singh (634211) Kevin Boyd (4837608) Extracorporeal Shockwave Therapy Tendons Outcome Assessment Greater Trochanteric Pain Syndrome <div>Objective: To investigate the outcomes following three weekly sessions of radial extra-corporeal shockwave therapy (rESWT) in patients with chronic greater trochanteric pain syndrome (GTPS) presenting to an NHS Sports Medicine Clinic in the UK.</div><div>Design: Double-blinded randomised controlled trial</div><div>Setting: A single NHS Sports Medicine Clinic, in the United Kingdom.</div><div>Patients: 120 patients in an NHS Sports Medicine clinic presenting with symptoms of GTPS that had failed to improve with a minimum of three months of rehabilitation were enrolled in the study, randomised equally to the intervention and treatment groups. Mean age 60.6±11.5years, 82% female, mean duration of symptoms 45.4±33.4 months (range: 6months-30years.)</div><div>Interventions: Participants were randomised to receive either three sessions of ESWT at either the “recommended”/“maximally comfortably tolerated” dose or at “minimal-dose”. All patients received a structured home exercise programme involving flexibility, strength and balance exercises.</div><div>Main outcome measures: Follow-up was 6-weeks, 3-months, and 6-months. Outcome measures included local hip pain, validated hip PROMs (OHS, NAHS, VISA-G) and wider measures of function including sleep (PSQI) and mood (HADS).</div><div>Results: Results were available for 98% of patients at the 6-month period. There were statistically significant within-group improvements in pain, local function, and sleep seen in both groups. However, fewer benefits were seen in other outcome measures including activity or mood.</div><div>Conclusion: There were no time*group interaction effects seen between the groups at any time-point, indicating that 3 sessions the “recommended-dose” rESWT had no measurable benefit compared to “minimal-dose” rESWT in this group of patients with GTPS. The underlying reason remains unclear, it may be that rESWT is ineffective in the treatment of patients with chronic GTPS, that “minimal-dose” rESWT is sufficient for a therapeutic effect, or that a greater number of treatment sessions are required for maximal benefit. These issues need to be considered in further research.</div> 2021-01-20T00:00:00Z Text Journal contribution 2134/12630968.v1 https://figshare.com/articles/journal_contribution/Three_sessions_of_radial_extracorporeal_shockwave_therapy_gives_no_additional_benefit_over_minimal-dose_radial_extracorporeal_shockwave_therapy_for_patients_with_chronic_greater_trochanteric_pain_syndrome_a_double-blinded_randomized_control/12630968 CC BY-NC 4.0 |
| spellingShingle | Extracorporeal Shockwave Therapy Tendons Outcome Assessment Greater Trochanteric Pain Syndrome Patrick Wheeler Chloe Dudson Rachel Calver Duncan Goodall Kim Gregory Harjinder Singh Kevin Boyd Three sessions of radial extracorporeal shockwave therapy gives no additional benefit over “minimal-dose” radial extracorporeal shockwave therapy for patients with chronic greater trochanteric pain syndrome: a double-blinded, randomized, controlled trial |
| title | Three sessions of radial extracorporeal shockwave therapy gives no additional benefit over “minimal-dose” radial extracorporeal shockwave therapy for patients with chronic greater trochanteric pain syndrome: a double-blinded, randomized, controlled trial |
| title_full | Three sessions of radial extracorporeal shockwave therapy gives no additional benefit over “minimal-dose” radial extracorporeal shockwave therapy for patients with chronic greater trochanteric pain syndrome: a double-blinded, randomized, controlled trial |
| title_fullStr | Three sessions of radial extracorporeal shockwave therapy gives no additional benefit over “minimal-dose” radial extracorporeal shockwave therapy for patients with chronic greater trochanteric pain syndrome: a double-blinded, randomized, controlled trial |
| title_full_unstemmed | Three sessions of radial extracorporeal shockwave therapy gives no additional benefit over “minimal-dose” radial extracorporeal shockwave therapy for patients with chronic greater trochanteric pain syndrome: a double-blinded, randomized, controlled trial |
| title_short | Three sessions of radial extracorporeal shockwave therapy gives no additional benefit over “minimal-dose” radial extracorporeal shockwave therapy for patients with chronic greater trochanteric pain syndrome: a double-blinded, randomized, controlled trial |
| title_sort | three sessions of radial extracorporeal shockwave therapy gives no additional benefit over “minimal-dose” radial extracorporeal shockwave therapy for patients with chronic greater trochanteric pain syndrome: a double-blinded, randomized, controlled trial |
| topic | Extracorporeal Shockwave Therapy Tendons Outcome Assessment Greater Trochanteric Pain Syndrome |
| url | https://hdl.handle.net/2134/12630968.v1 |